Compugen reported $1.26M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 1.26M 211K Jun/2025
Life Technologies USD 2.22M 2.22M Jun/2025
RedHill Biopharma USD 1.29M 722K Jun/2024